| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-02-14 | Casdin Capital, LLC | Relay Therapeutics, Inc. | 7,387,943 | 6.0% | EDGAR |
| SC 13G | 2024-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | Relay Therapeutics, Inc. | 8,589,425 | 7.0% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Relay Therapeutics, Inc. | 10,650,387 | 8.6% | EDGAR |
| SC 13G/A | 2024-01-26 | BlackRock Inc. | Relay Therapeutics, Inc. | 9,573,423 | 7.8% | EDGAR |
| SC 13G/A | 2024-01-23 | STATE STREET CORP | Relay Therapeutics, Inc. | - | 4.0% | EDGAR |
| SC 13G | 2023-10-02 | Casdin Capital, LLC | Relay Therapeutics, Inc. | 6,298,574 | 5.2% | EDGAR |
| SC 13G/A | 2023-07-10 | FMR LLC | Relay Therapeutics, Inc. | 2,956,221 | 2.4% | EDGAR |
| SC 13G/A | 2023-02-09 | FMR LLC | Relay Therapeutics, Inc. | 9,733,848 | 8.1% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Relay Therapeutics, Inc. | 10,384,218 | 8.6% | EDGAR |
| SC 13G | 2023-02-03 | STATE STREET CORP | Relay Therapeutics, Inc. | - | 5.2% | EDGAR |
| SC 13G/A | 2023-02-01 | BlackRock Inc. | Relay Therapeutics, Inc. | 7,997,985 | 6.6% | EDGAR |
| SC 13G/A | 2022-10-11 | FMR LLC | Relay Therapeutics, Inc. | 11,958,212 | 9.9% | EDGAR |
| SC 13G/A | 2022-02-14 | Third Rock Ventures III, L.P. | Relay Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2022-02-10 | VANGUARD GROUP INC | Relay Therapeutics, Inc. | 6,198,442 | 5.7% | EDGAR |
| SC 13G/A | 2022-02-09 | FMR LLC | Relay Therapeutics, Inc. | 16,206,601 | 15.0% | EDGAR |
| SC 13G | 2022-02-04 | BlackRock Inc. | Relay Therapeutics, Inc. | 5,993,613 | 5.5% | EDGAR |
| SC 13G/A | 2021-07-12 | FMR LLC | Relay Therapeutics, Inc. | 10,362,000 | 11.2% | EDGAR |
| SC 13G | 2021-02-16 | SB INVESTMENT ADVISERS (UK) LTD | Relay Therapeutics, Inc. | 27,904,963 | 31.0% | EDGAR |
| SC 13G | 2021-02-16 | Third Rock Ventures III, L.P. | Relay Therapeutics, Inc. | 10,551,115 | 11.7% | EDGAR |
| SC 13G | 2021-02-08 | FMR LLC | Relay Therapeutics, Inc. | 4,762,238 | 5.3% | EDGAR |